ECSP066558A - Metodos y composiciones para la inhibicion de selectina - Google Patents
Metodos y composiciones para la inhibicion de selectinaInfo
- Publication number
- ECSP066558A ECSP066558A EC2006006558A ECSP066558A ECSP066558A EC SP066558 A ECSP066558 A EC SP066558A EC 2006006558 A EC2006006558 A EC 2006006558A EC SP066558 A ECSP066558 A EC SP066558A EC SP066558 A ECSP066558 A EC SP066558A
- Authority
- EC
- Ecuador
- Prior art keywords
- methods
- compositions
- selectin inhibition
- selectin
- inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
La presente invención se relaciona con el campo de sustancias antiinflamatorias y más particularmente con compuestos novedosos que actúan como antagonistas de las proteínas de adhesión de mamíferos conocidas como selectinas. En algunas modalidades, los métodos para tratar los trastornos mediados por selectina están proporcionados e incluyen la administración del compuesto de la Fórmula I donde las variables constitutivas se definen aquí.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51895003P | 2003-11-10 | 2003-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP066558A true ECSP066558A (es) | 2006-10-17 |
Family
ID=34590327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006006558A ECSP066558A (es) | 2003-11-10 | 2006-05-10 | Metodos y composiciones para la inhibicion de selectina |
Country Status (21)
Country | Link |
---|---|
US (2) | US7465799B2 (es) |
EP (1) | EP1682511A2 (es) |
JP (1) | JP2007510742A (es) |
KR (1) | KR20060108666A (es) |
CN (1) | CN1902179A (es) |
AR (1) | AR046704A1 (es) |
AU (1) | AU2004288800A1 (es) |
BR (1) | BRPI0416357A (es) |
CA (1) | CA2544693A1 (es) |
CO (1) | CO5690556A2 (es) |
CR (1) | CR8384A (es) |
EC (1) | ECSP066558A (es) |
GT (1) | GT200400232A (es) |
IL (1) | IL175389A0 (es) |
NO (1) | NO20062348L (es) |
PA (1) | PA8617101A1 (es) |
PE (1) | PE20050579A1 (es) |
RU (1) | RU2006120450A (es) |
TW (1) | TW200526583A (es) |
WO (1) | WO2005047257A2 (es) |
ZA (1) | ZA200603683B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2006120489A (ru) * | 2003-11-10 | 2007-12-20 | Уайт (Us) | Способы и композиции, предназначенные для ингибирования селектина |
US8686002B2 (en) * | 2005-08-21 | 2014-04-01 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
US20080125454A1 (en) * | 2006-10-05 | 2008-05-29 | Wyeth | Methods and Compositions for Treatment of Scleritis and Related Disorders |
US20080255192A1 (en) * | 2007-03-30 | 2008-10-16 | Wyeth | Methods and Compositions for Selectin Inhibition |
MX2009010514A (es) | 2007-03-30 | 2009-10-19 | Wyeth Corp | Metodos y composiciones para la inhibicion de selectina. |
EP2379076B1 (en) | 2008-12-23 | 2014-11-12 | The Trustees of Columbia University in the City of New York | Phosphodiesterase inhibitors and uses thereof |
US11946927B2 (en) | 2016-03-14 | 2024-04-02 | Musidora Biotechnology Llc | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
US10295527B2 (en) | 2016-03-14 | 2019-05-21 | Bruce Yacyshyn | Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843707A (en) | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
US6083944A (en) * | 1997-10-07 | 2000-07-04 | Cephalon, Inc. | Quinoline-containing α-ketoamide cysteine and serine protease inhibitors |
AU1804299A (en) * | 1997-12-08 | 1999-06-28 | Glycomed Incorporated | Sialyl lewis x and sialyl lewis a glycomimetics |
US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1406621A2 (en) | 2001-06-26 | 2004-04-14 | Beth Israel Deaconess Medical Center | Compositions and methods for inhibiting platelet activation and thrombosis |
EP1422782B1 (en) * | 2001-07-06 | 2011-01-12 | Nippon Kayaku Kabushiki Kaisha | Photoelectric conversion element sensitized with methine dyes |
-
2004
- 2004-11-09 AR ARP040104129A patent/AR046704A1/es unknown
- 2004-11-09 BR BRPI0416357-5A patent/BRPI0416357A/pt not_active IP Right Cessation
- 2004-11-09 RU RU2006120450/04A patent/RU2006120450A/ru not_active Application Discontinuation
- 2004-11-09 WO PCT/US2004/037334 patent/WO2005047257A2/en active Application Filing
- 2004-11-09 CN CNA2004800397576A patent/CN1902179A/zh not_active Withdrawn
- 2004-11-09 KR KR1020067008995A patent/KR20060108666A/ko not_active Application Discontinuation
- 2004-11-09 TW TW093134111A patent/TW200526583A/zh unknown
- 2004-11-09 AU AU2004288800A patent/AU2004288800A1/en not_active Withdrawn
- 2004-11-09 PE PE2004001095A patent/PE20050579A1/es not_active Application Discontinuation
- 2004-11-09 CA CA002544693A patent/CA2544693A1/en not_active Abandoned
- 2004-11-09 JP JP2006539741A patent/JP2007510742A/ja not_active Withdrawn
- 2004-11-09 PA PA20048617101A patent/PA8617101A1/es unknown
- 2004-11-09 EP EP04818666A patent/EP1682511A2/en not_active Withdrawn
- 2004-11-09 US US10/984,093 patent/US7465799B2/en not_active Expired - Fee Related
- 2004-11-09 GT GT200400232A patent/GT200400232A/es unknown
-
2006
- 2006-05-02 IL IL175389A patent/IL175389A0/en unknown
- 2006-05-05 CR CR8384A patent/CR8384A/es not_active Application Discontinuation
- 2006-05-09 ZA ZA200603683A patent/ZA200603683B/en unknown
- 2006-05-10 EC EC2006006558A patent/ECSP066558A/es unknown
- 2006-05-12 CO CO06045580A patent/CO5690556A2/es not_active Application Discontinuation
- 2006-05-23 NO NO20062348A patent/NO20062348L/no not_active Application Discontinuation
-
2008
- 2008-11-11 US US12/268,681 patent/US20090076077A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR046704A1 (es) | 2005-12-21 |
BRPI0416357A (pt) | 2007-05-08 |
RU2006120450A (ru) | 2007-12-27 |
EP1682511A2 (en) | 2006-07-26 |
JP2007510742A (ja) | 2007-04-26 |
WO2005047257A2 (en) | 2005-05-26 |
CO5690556A2 (es) | 2006-10-31 |
PE20050579A1 (es) | 2005-09-08 |
GT200400232A (es) | 2005-09-14 |
CA2544693A1 (en) | 2005-05-26 |
US7465799B2 (en) | 2008-12-16 |
PA8617101A1 (es) | 2006-09-22 |
WO2005047257A3 (en) | 2005-07-07 |
CN1902179A (zh) | 2007-01-24 |
IL175389A0 (en) | 2006-09-05 |
AU2004288800A1 (en) | 2005-05-26 |
ZA200603683B (en) | 2008-05-28 |
KR20060108666A (ko) | 2006-10-18 |
US20050101568A1 (en) | 2005-05-12 |
NO20062348L (no) | 2006-08-01 |
CR8384A (es) | 2006-12-07 |
TW200526583A (en) | 2005-08-16 |
US20090076077A1 (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066557A (es) | Métodos y composiciones para inhibición de selectina | |
CL2021002995A1 (es) | (divisional de solicitud 2922-2020) derivados de tetrahidro-imidazo[4,5-c]piridina como inmunomoduladores de pd-l1. | |
ECSP066558A (es) | Metodos y composiciones para la inhibicion de selectina | |
ECSP20069418A (es) | Compuestos heterocíclicos como inmunomoduladores | |
UY30220A1 (es) | Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo | |
ECSP088774A (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricación. | |
BR112018067775A2 (pt) | inibidores de mcl-1 indol substituído | |
UY29414A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
BR112014000792A2 (pt) | compostos de piperidinila para uso como inibidores da tanquirase | |
CR10288A (es) | Pirazoles como inhibidores de la 11-beta-hsd1 | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
BRPI0915692B8 (pt) | compostos derivados de 1,2,5-oxadiazóis, sua forma sólida, sua composição, bem como seus usos | |
GT200900027A (es) | Compuestos organicos | |
ECSP088590A (es) | Derivados de aminoácido multicíclicos y sus métodos de uso | |
EA201100503A1 (ru) | Глюкозидные производные и их применения | |
PA8842101A1 (es) | Heteroarilos sustituidos | |
UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
UY29343A1 (es) | Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso. | |
CL2008000202A1 (es) | Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor. | |
CO2021001219A2 (es) | Benzimidazoles sustituidos como inhibidores de pad4 | |
CL2010001566A1 (es) | Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune. | |
SV2011003839A (es) | Agentes antifungicos | |
ECSP088242A (es) | Combinaciones que comprenden dmxaa para el tratamiento de cancer | |
CR11860A (es) | Derivados de dibenzotiazepina y sus usos - 424 | |
CL2021000282A1 (es) | Inhibidores de ckd8/19 |